Literature DB >> 29427663

Intracellular formyl peptide receptor regulates naïve CD4 T cell migration.

Ha Young Lee1, Yu Sun Jeong2, Mingyu Lee3, Hee-Seok Kweon4, Yang Hoon Huh4, Joon Seong Park5, Ji Eun Hwang6, Kyuseok Kim6, Yoe-Sik Bae7.   

Abstract

We found that formyl peptide receptor (FPR) 1 and FPR3 were expressed intracellularly and/or the nucleus of naïve CD4 T cell. Activation of naïve CD4 T cells with synthetic intracellular agonists dTAT-WKYMVm and CTP-WKYMVm for FPR members stimulated CD4 T cell migration via pertussis toxin-sensitive manner. Knockdown of FPR1, but not knockdown of FPR3, blocked dTAT-WKYMVm-induced naïve CD4 T cell migration. Stimulation of naïve CD4 T cells with dTAT-WKYMVm elicited the activation of ERK, p38 MAPK, and Akt. Activation of CD4 T cells with anti-CD3 and anti-CD28 antibodies caused surface expression of FPR1 and FPR3, but not FPR2. CD4 T cells isolated from sepsis patients expressed the three members of FPR family on their cell surface. Taken together, our results suggest that intracellular FPR in naïve CD4 T cells and surface FPRs in activated CD4 T cells might regulate immune responses by regulating CD4 T cell activity.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD4 T cells; Formyl peptide receptor; Intraceullar G-protein coupled receptor; Migration; Sepsis

Mesh:

Substances:

Year:  2018        PMID: 29427663     DOI: 10.1016/j.bbrc.2018.02.060

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer.

Authors:  Tao-Wei Ke; Shu-Fen Chiang; Kevin Chih-Yang Huang; William Tzu-Liang Chen; Tsung-Wei Chen; K S Clifford Chao
Journal:  Cancer Immunol Immunother       Date:  2021-03-13       Impact factor: 6.968

2.  Suppression of autoreactive T and B lymphocytes by anti-annexin A1 antibody in a humanized NSG murine model of systemic lupus erythematosus.

Authors:  N Mihaylova; P Chipinski; S Bradyanova; T Velikova; E Ivanova-Todorova; S Chausheva; M Herbáth; D Kalinova; J Prechl; D Kyurkchiev; A I Tchorbanov
Journal:  Clin Exp Immunol       Date:  2019-12-04       Impact factor: 4.330

3.  Peptides from allergenic lipocalins bind to formyl peptide receptor 3 in human dendritic cells to mediate TH2 immunity.

Authors:  Dominik Klaver; Beate Posch; Anita Geisler; Martin Hermann; Norbert Reider; Christine Heufler
Journal:  J Allergy Clin Immunol       Date:  2019-07-19       Impact factor: 10.793

4.  Six Immune Associated Genes Construct Prognostic Model Evaluate Low-Grade Glioma.

Authors:  Yin Qiu Tan; Yun Tao Li; Teng Feng Yan; Yang Xu; Bao Hui Liu; Ji An Yang; Xue Yang; Qian Xue Chen; Hong Bo Zhang
Journal:  Front Immunol       Date:  2020-12-21       Impact factor: 7.561

5.  Identification of key pathways and core genes involved in atherosclerotic plaque progression.

Authors:  Rong Yang; Linpeng Yao; Chengli Du; Yihe Wu
Journal:  Ann Transl Med       Date:  2021-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.